Versatile flexible micelles integrating mucosal penetration and intestinal targeting for effectively oral delivery of paclitaxel.
- Author:
Chao LIU
1
;
Wei LIU
1
;
Yanhong LIU
1
;
Hongxia DUAN
1
;
Liqing CHEN
1
;
Xintong ZHANG
1
;
Mingji JIN
1
;
Minhu CUI
2
;
Xiuquan QUAN
2
;
Libin PAN
1
;
Jiachun HU
1
;
Zhonggao GAO
1
;
Yan WANG
1
;
Wei HUANG
1
Author Information
- Publication Type:Journal Article
- Keywords: Bile acids; Bioavailability; Chemotherapy; Intestine epithelium targeting; Mucus penetration; Oral nanoparticles; Paclitaxel; Trans-epithelium
- From: Acta Pharmaceutica Sinica B 2023;13(8):3425-3443
- CountryChina
- Language:English
- Abstract: The extremely low bioavailability of oral paclitaxel (PTX) mainly due to the complicated gastrointestinal environment, the obstruction of intestinal mucus layer and epithelium barrier. Thus, it is of great significance to construct a coordinative delivery system which can overcome multiple intestinal physicochemical obstacles simultaneously. In this work, a high-density PEGylation-based glycocholic acid-decorated micelles (PTX@GNPs) was constructed by a novel polymer, 9-Fluorenylmethoxycarbonyl-polyethylene glycocholic acid (Fmoc-PEG-GCA). The Fmoc motif in this polymer could encapsulate PTX via π‒π stacking to form the core of micelles, and the low molecular weight and non-long hydrophobic chain of Fmoc ensures the high-density of PEG. Based on this versatile and flexible carriers, PTX@GNPs possess mucus trapping escape ability due to the flexible PEG, and excellent intestine epithelium targeting attributed to the high affinity of GCA with apical sodium-dependent bile acid transporter. The in vitro and in vivo results showed that this oral micelle could enhance oral bioavailability of PTX, and exhibited similar antitumor efficacy to Taxol injection via intravenous route. In addition, oral PTX@GNPs administered with lower dosage within shorter interval could increase in vivo retention time of PTX, which supposed to remodel immune microenvironment and enhance oral chemotherapy efficacy by synergistic effect.